• Immunologic Deficiency Syndrome Treatment Market Size in 7MM openPR.com Mon, 21 Apr 2025 12:56:00 GMT
• A Cure for Cancer? How CAR-T Cell Therapy is Revolutionizing Oncology Labiotech.eu Mon, 17 Mar 2025 07:00:00 GMT
• pre-market movers in healthcare sector: blcm, nvax, nmtr, nuro, cgix… RTTNews Wed, 26 Feb 2025 03:11:13 GMT
• blcm (bellicum pharmaceuticals) eps without nri : $-0.77 (ttm as of sep. 2023) GuruFocus.com Mon, 03 Feb 2025 09:05:35 GMT
• bellicum pharmaceuticals (fra:bpxa) enterprise value : €-40.78 mil (as of jan. 11, 2025) GuruFocus.com Sat, 11 Jan 2025 11:53:47 GMT
• bellicum pharmaceuticals (fra:bpxa) ps ratio : 3.62 (as of jan. 06, 2025) GuruFocus.com Mon, 06 Jan 2025 09:52:52 GMT
• PSCA-targeted BPX-601 CAR T cells with pharmacological activation by rimiducid in metastatic pancreatic and prostate cancer: a pha... Nature Mon, 30 Dec 2024 08:00:00 GMT
• hemophagocytic lymphohistiocytosis market size, share, epidemiology and market forecast 2034 | a2b bio ltd, bellicum pharmaceutica... Barchart Mon, 02 Dec 2024 12:52:57 GMT
• bellicum pharmaceuticals (stu:bpxa) roc (joel greenblatt) % : -24,166.67% (as of sep. 2023) GuruFocus.com Sun, 01 Dec 2024 11:40:02 GMT
• (pdf) leuprolide acetate given by a subcutaneous extended-release injection: less of a pain? ResearchGate Thu, 21 Nov 2024 08:00:00 GMT
• longeveron strengthens leadership: key executive hire ahead of critical bla submission StockTitan Mon, 11 Nov 2024 08:00:00 GMT
• hemophagocytic lymphohistiocytosis market to reach new heights in growth by 2034, delveinsight predict | incyte, novartis, atara b... The Globe and Mail Thu, 31 Oct 2024 07:00:00 GMT
• Allogeneic Hematopoietic Stem Cell Transplant Market to GlobeNewswire Mon, 21 Oct 2024 07:00:00 GMT
• thoroughbred financial services llc acquires new holdings in belden inc. (nyse:bdc) Defense World Wed, 18 Sep 2024 18:55:08 GMT
• belden shares target raised, keeps buy rating on strong growth outlook Investing.com Wed, 18 Sep 2024 15:18:57 GMT
• oppenheimer asset management inc. purchases 13,583 shares of bellring brands, inc. (nyse:brbr) Defense World Wed, 18 Sep 2024 11:52:43 GMT
• oppenheimer & co. inc. purchases 4,814 shares of builders firstsource, inc. (nyse:bldr) MarketBeat Mon, 16 Sep 2024 13:35:08 GMT
• oppenheimer & co. inc. boosts stake in builders firstsource, inc. (nyse:bldr) Defense World Mon, 16 Sep 2024 12:29:57 GMT
• winton group ltd buys 29,060 shares of bellring brands, inc. (nyse:brbr) MarketBeat Sun, 15 Sep 2024 12:32:31 GMT
• bellicum pharmaceuticals (stu:bpxa) ev-to-revenue : -3.48 (as of aug. 19, 2024) GuruFocus.com Tue, 20 Aug 2024 01:40:09 GMT
• blcm (bellicum pharmaceuticals) earnings per share (diluted) : $-0.72 (ttm as of sep. 2023) GuruFocus.com Tue, 20 Aug 2024 00:02:16 GMT
• blcm (bellicum pharmaceuticals) debt-to-revenue : 0.00 (as of sep. 2023) GuruFocus.com Mon, 19 Aug 2024 04:29:36 GMT
• bellicum pharmaceuticals (stu:bpxa) return-on-tangible-asse GuruFocus.com Sun, 18 Aug 2024 07:37:10 GMT
• emerging opportunities in the personalized cell therapy market openPR Fri, 02 Aug 2024 08:41:00 GMT
• global osteosarcoma market 2024 analysis by top key players |advaxis inc., baxter, pfizer, bellicum pharmaceuticals The NRI News Tue, 30 Jul 2024 06:58:08 GMT
• [top trends] engineered t cells market | autolus limited, bellicum pharmaceuticals, cells medica – economica Economica Sun, 07 Jul 2024 04:51:16 GMT
• chimeric antigen receptor t cell therapy market [2024-2031] | amgen, bellicum pharmaceuticals, bluebird bio ... Economica Sat, 06 Jul 2024 11:29:29 GMT
• personalized cell therapy market key strategy matrices | novartis ag, vericel corporation, bellicum pharmaceuticals ... Economica Fri, 05 Jul 2024 19:00:23 GMT
• engineered t cells market to expand with significant cagr by 2034 |autolus limited, bellicum pharmaceuticals, cells medi – knowcas... KnowCasino Thu, 04 Jul 2024 19:52:25 GMT
• sickle cell disease pipeline assessment 2024: ema, pdma, fda approvals, clinical trials, therapies, moa, roa and ... openPR Thu, 20 Jun 2024 12:02:00 GMT
• histiocytosis treatment market is booming globally by 2030 | ab2 bio ltd., alpine immune sciencs, bellicum ... PrimePair Thu, 20 Jun 2024 08:07:55 GMT
• buzz-u.s. stocks on the move-first marblehead, bellicum, ovascience Yahoo Movies UK Sun, 26 May 2024 20:28:15 GMT
• is bellicum pharmaceuticals (blcm) stock outpacing its medical peers this year? Yahoo Lifestyle Australia Sun, 26 May 2024 12:31:08 GMT
• bellicum pharmaceuticals (blcm) could find support soon, here's why you should buy the stock now Yahoo New Zealand News Wed, 22 May 2024 03:54:56 GMT
• is bellicum pharmaceuticals (blcm) stock outpacing its medical peers this year? Yahoo Lifestyle Australia Wed, 22 May 2024 01:58:00 GMT
• chimeric antigen receptor t cell therapy market [2024-2031] | amgen, bellicum pharmaceuticals, bluebird bio Motions Online Wed, 08 May 2024 05:18:56 GMT
• cronos group (cron) catches eye: stock jumps 9.3% Yahoo Canada Shine On Mon, 06 May 2024 07:15:05 GMT
• chimeric antigen receptor t cell therapy market 2024 key insights | amgen, bellicum pharmaceuticals, bluebird bio ... Amoré Tue, 30 Apr 2024 12:06:48 GMT
• personalized cell therapy market key strategy matrices | novartis ag, vericel corporation, bellicum pharmaceuticals ... Motions Online Tue, 30 Apr 2024 05:29:29 GMT
• bellicum pharmaceuticals (stu:bpxa) roa % : -39.50% (as of sep. 2023) GuruFocus.com Fri, 26 Apr 2024 21:15:12 GMT
• bellicum pharmaceuticals (stu:bpxa) profitability rank : 0 (as of sep. 2023) GuruFocus.com Fri, 26 Apr 2024 18:05:49 GMT
• caspase 9 market is thriving worldwide- bellicum pharmaceuticals inc, beyondspring pharmaceuticals inc, conatus ... Post Production Buyers Guide Wed, 17 Apr 2024 08:12:32 GMT
• bellicum pharmaceuticals (nasdaq:blcm) share price crosses above 50-day moving average of $0.08 Defense World Tue, 16 Apr 2024 08:02:41 GMT
• bellicum pharmaceuticals (nasdaq:blcm) receives new coverage from analysts at stocknews.com Defense World Tue, 16 Apr 2024 07:00:00 GMT
• bellicum (blcm) down on ending development of car-t candidates Yahoo Movies UK Mon, 15 Apr 2024 09:30:36 GMT
• better buy: bellicum pharmaceuticals, inc. vs. alnylam Yahoo Movies Canada Sun, 14 Apr 2024 22:17:33 GMT
• bellicum (blcm) down on ending development of car-t candidates Yahoo Movies UK Sat, 13 Apr 2024 18:36:23 GMT
• sickle cell disease pipeline analysis 2024: fda, ema, and pdma approvals, clinical trials, mechanisms of action ... openPR Tue, 09 Apr 2024 15:07:00 GMT
• stocknews.com begins coverage on bellicum pharmaceuticals (nasdaq:blcm) Defense World Mon, 08 Apr 2024 06:24:35 GMT
• bellicum pharmaceuticals (nasdaq:blcm) coverage initiated at stocknews.com Defense World Sun, 31 Mar 2024 06:16:13 GMT
• a cure for cancer? how car-t cell therapy is revolutionizing oncology Labiotech.eu Mon, 25 Mar 2024 07:00:00 GMT
• bellicum pharmaceuticals (nasdaq:blcm) stock price passes above fifty day moving average of $0.09 Defense World Sat, 23 Mar 2024 08:06:38 GMT
• bellicum pharmaceuticals (nasdaq:blcm) coverage initiated by analysts at stocknews.com Defense World Sat, 23 Mar 2024 06:31:14 GMT
• personalized cell therapy market key strategy matrices | novartis ag, vericel corporation, bellicum pharmaceuticals Amoré Tue, 19 Mar 2024 10:11:47 GMT
• latest breakthroughs in sickle cell disease pipeline 2024: regulatory approvals, clinical trials, innovations, and key ... openPR Tue, 19 Mar 2024 04:56:00 GMT
• bellicum pharmaceuticals (nasdaq:blcm) stock passes above 50-day moving average of $0.09 Defense World Fri, 15 Mar 2024 10:38:11 GMT
• bellicum pharmaceuticals (nasdaq:blcm) receives new coverage from analysts at stocknews.com American Banking News Fri, 15 Mar 2024 08:01:18 GMT
• bellicum pharmaceuticals (nasdaq:blcm) research coverage started at stocknews.com Defense World Fri, 15 Mar 2024 07:11:07 GMT
• analyst reaffirms positive outlook on adc therapeutics with price target of 8 Best Stocks Thu, 14 Mar 2024 18:42:26 GMT
• alpha thalassemia treatment industry [swot analysis]| glaxosmithkline, novartis ag, bellicum pharmaceuticals Amoré Thu, 14 Mar 2024 10:40:40 GMT
• chimeric antigen receptor t cell therapy market [2024-2031] | amgen, bellicum pharmaceuticals, bluebird bio Amoré Wed, 13 Mar 2024 03:27:23 GMT
• analyst reaffirms market outperform rating for larimar therapeutics with 25 price target Best Stocks Tue, 12 Mar 2024 16:01:35 GMT
• is bellicum pharmaceuticals (blcm) outperforming other medical stocks this year? Yahoo News Canada Tue, 12 Mar 2024 09:39:08 GMT
• is bellicum pharmaceuticals (blcm) outperforming other medical stocks this year? Yahoo News Canada Mon, 11 Mar 2024 17:39:08 GMT
• md anderson cancer center acquires cell therapy switch technologies from bellicum LabPulse Thu, 07 Mar 2024 08:00:00 GMT
• bellicum pharmaceuticals (nasdaq:blcm) research coverage started at stocknews.com Defense World Thu, 07 Mar 2024 08:00:00 GMT
• cell therapy vendors: news from miltenyi and saint-gobain BioProcess Insider Mon, 04 Mar 2024 23:54:47 GMT
• minimal residual disease market to expand at a significant growth rate during the forecast period (2023-32 ... 매일세종 Fri, 01 Mar 2024 15:29:55 GMT
• bellicum pharmaceuticals (nasdaq:blcm) earns sell rating from analysts at stocknews.com AmericanBankingNEWS Wed, 28 Feb 2024 07:21:28 GMT
• Bellicum Pharmaceuticals Appoints New CEO During Dissolution TipRanks Sat, 24 Feb 2024 08:00:00 GMT
• md anderson acquires cell therapy safety technology from bellicum pharmaceuticals News-Medical.Net Fri, 23 Feb 2024 02:37:00 GMT
• pioneering the future of cancer therapy: md anderson acquires bellicum pharmaceuticals' assets BNN Breaking Thu, 22 Feb 2024 23:10:06 GMT
• MD Anderson acquires inducible switch technologies for cell therapy MD Anderson Cancer Center Thu, 22 Feb 2024 08:00:00 GMT
• md anderson acquires cell therapy safety technology from bellicum pharmaceuticals News-Medical.Net Thu, 22 Feb 2024 08:00:00 GMT
• bellicum sells assets to md anderson, moves towards liquidation (otcmkts:blcm) Seeking Alpha Thu, 22 Feb 2024 08:00:00 GMT
• Bellicum Pharmaceuticals Finalizes Sale and Approves Dissolution TipRanks Wed, 21 Feb 2024 08:00:00 GMT
• bellicum pharmaceuticals (nasdaq:blcm) stock passes below fifty day moving average of $0.13 Defense World Tue, 20 Feb 2024 14:03:45 GMT
• bellicum pharmaceuticals (nasdaq:blcm) shares pass below fifty day moving average of $0.13 AmericanBankingNEWS Tue, 20 Feb 2024 08:00:00 GMT
• bellicum pharmaceuticals (nasdaq:blcm) coverage initiated by analysts at stocknews.com Defense World Tue, 20 Feb 2024 07:38:10 GMT
• personalized cell therapy market research and scope: 2024, explosive growth factors and forecast to 2031 openPR Mon, 19 Feb 2024 08:00:00 GMT
• bellicum pharmaceuticals (nasdaq:blcm) now covered by analysts at stocknews.com American Banking News Tue, 13 Feb 2024 08:00:00 GMT
• bellicum pharmaceuticals (nasdaq:blcm) earns sell rating from analysts at stocknews.com Defense World Mon, 12 Feb 2024 06:29:39 GMT
• stocknews.com initiates coverage on bellicum pharmaceuticals (nasdaq:blcm) Defense World Sun, 04 Feb 2024 06:33:54 GMT
• chronic granulomatous disease (cgd) treatment market expected to grow exponentially by 2029 | orchard ... The Nelson Post Sat, 03 Feb 2024 00:27:10 GMT
• Bellicum Pharmaceuticals Asset Sale and Dissolution Vote Adjourned TipRanks Wed, 31 Jan 2024 08:00:00 GMT
• knee bursitis treatment market 2024 growth opportunities and future outlook | top companies merrimack ... Amoré Sat, 27 Jan 2024 13:52:39 GMT
• bellicum pharmaceuticals introduces super-voting shares and changes quorum requirement TipRanks Thu, 25 Jan 2024 08:00:00 GMT
• bellicum pharmaceuticals asset sale and dissolution vote adjourned - tipranks.com TipRanks Thu, 25 Jan 2024 08:00:00 GMT
• bellicum pharmaceuticals issues super-voting share privately - tipranks.com TipRanks Thu, 25 Jan 2024 08:00:00 GMT
• rhabdomyosarcoma drug market – 37% of growth to originate from apac -bellicum pharmaceuticals inc, boehringer ... Artrocker Thu, 25 Jan 2024 02:51:43 GMT
• bellicum pharmaceuticals asset sale and dissolution vote adjourned - tipranks.com TipRanks Wed, 24 Jan 2024 08:00:00 GMT
• chronic granulomatous disease (cgd) treatment market developments 2030 |clinigen group plc, orchard ... Future of Media Sun, 14 Jan 2024 15:00:53 GMT
• caspase 9 market analysis competitive landscape, growth factors, revenue |bellicum pharmaceuticals inc ... Future of Media Fri, 12 Jan 2024 17:47:53 GMT
• bone marrow transplant rejection treatment rapidly growing market globally |bellicum pharmaceuticals, inc., bio ... Future of Media Fri, 12 Jan 2024 14:31:28 GMT
• advancements in sickle cell disease therapies: updates on fda, ema, and pdma approvals, clinical trials, mecha openPR Mon, 08 Jan 2024 08:00:00 GMT
• bellicum pharmaceuticals (nasdaq:blcm) now covered by analysts at stocknews.com Defense World Wed, 03 Jan 2024 06:35:41 GMT
• bone marrow transplant market – 37% of growth to originate from apac -bellicum pharmaceuticals, inc., bio-cancer ... Rough Cut Reviews Tue, 02 Jan 2024 12:18:55 GMT
• engineered t cells market to expand with significant cagr by 2029 |autolus limited, bellicum pharmaceuticals, cells ... Rough Cut Reviews Tue, 02 Jan 2024 04:57:13 GMT
• rhabdomyosarcoma drug market – a comprehensive study by key players: bellicum pharmaceuticals inc ... Rough Cut Reviews Tue, 02 Jan 2024 04:52:21 GMT
• personalized cell therapy market year 2029|novartis ag, vericel corporation, bellicum pharmaceuticals, molmed ... Rough Cut Reviews Mon, 01 Jan 2024 09:36:42 GMT
• stocknews.com initiates coverage on bellicum pharmaceuticals (nasdaq:blcm) Defense World Tue, 26 Dec 2023 06:28:16 GMT
• personalized cell therapy market enhancement in various sector 2023 to 2030 | bellicum pharmaceuticals, inc EIN News Wed, 20 Dec 2023 12:01:00 GMT
• bellicum pharmaceuticals (nasdaq:blcm) coverage initiated at stocknews.com Defense World Mon, 18 Dec 2023 06:33:54 GMT
• chimeric antigen receptor t cell therapy market booming worldwide with latest trend and future scope with top ... salisburyandstonehenge Thu, 14 Dec 2023 10:43:42 GMT
• hemophagocytic lymphohistiocytosis market to make great impact in near future over 2030 sobi, ab2 bio ltd, alpine ... salisburyandstonehenge Fri, 08 Dec 2023 05:55:40 GMT
• personalized cell therapy market to see booming growth 2023-2030 | cytori therapeutics inc., bellicum ... Digital Journal Thu, 07 Dec 2023 10:48:03 GMT
• rhabdomyosarcoma drug market – a comprehensive study by key players: bellicum pharmaceuticals inc ... Artrocker Wed, 06 Dec 2023 10:50:52 GMT
• alpha thalassemia treatment market growing rapidly by-glaxosmithkline, novartis ag, bellicum pharmaceuticals ... Artrocker Mon, 04 Dec 2023 07:13:22 GMT
• chimeric antigen receptor t cell therapy industry to set phenomenal growth from 2023 to 2029 |amgen, bellicum ... Artrocker Mon, 04 Dec 2023 05:16:16 GMT
• chronic granulomatous disease (cgd) treatment market to witness tremendous growth by 2029 |clinigen group plc ... Argyle Report Sun, 03 Dec 2023 17:20:40 GMT
• bellicum pharmaceuticals (nasdaq:blcm) share price crosses above 50-day moving average of $0.22 Defense World Sat, 02 Dec 2023 08:00:00 GMT
• engineered t cells industry to witness exponential growth by 2030 | autolus limited, bellicum pharmaceuticals, cells ... salisburyandstonehenge Fri, 01 Dec 2023 10:15:34 GMT
• personalized cell therapy market trends, companies and rapid growth by 2030 | bellicum pharmaceuticals, molmed ... Argyle Report Fri, 01 Dec 2023 02:39:01 GMT
• chimeric antigen receptor cell therapy industry data and in-depth analysis to 2029 | beijing immunochina medical ... Argyle Report Tue, 28 Nov 2023 11:36:39 GMT
• adoptive cellular immunotherapy market is booming in the globe by 2029 |amgen inc, autolus therapeutics plc ... Argyle Report Wed, 22 Nov 2023 17:16:06 GMT
• xfra deletion of instruments from boerse frankfurt ... finanznachrichten.de Mon, 20 Nov 2023 19:19:00 GMT
• advanced gastric carcinoma clinical trial pipeline accelerates as ... GlobeNewswire Mon, 20 Nov 2023 18:01:35 GMT
• engineered t cells market product scope – autolus limited, bellicum pharmaceuticals, cells medica – argyle report Argyle Report Mon, 20 Nov 2023 04:49:36 GMT
• rhabdomyosarcoma drug industry growing rapidly globally | bellicum pharmaceuticals inc, iproteos sl, celgene ... Argyle Report Mon, 20 Nov 2023 02:29:57 GMT
• bellicum pharmaceuticals: q3 earnings snapshot San Francisco Chronicle Wed, 15 Nov 2023 08:00:00 GMT
• personalized cell therapy market growing rapidly by novartis ag, vericel corporation, bellicum pharmaceuticals ... Argyle Report Thu, 09 Nov 2023 11:32:16 GMT
• stocknews.com begins coverage on bellicum pharmaceuticals (nasdaq:blcm) Defense World Wed, 08 Nov 2023 08:21:34 GMT
• adoptive?cellular?immunotherapy market is booming worldwide – amgen inc, autolus therapeutics plc, beijing ... Argyle Report Mon, 06 Nov 2023 17:20:46 GMT
• pipeline moves: advancement prospects drop for hearing loss drug after trial termination Clinical Trials Arena Mon, 16 Oct 2023 07:00:00 GMT
• small-cell lung cancer market to accelerate substantially during ... PR Newswire Wed, 04 Oct 2023 07:00:00 GMT
• graft versus host disease market to witness upsurge in growth ... PR Newswire Wed, 27 Sep 2023 07:00:00 GMT
• bebe stores and bellicum pharmaceuticals on the list of winners and losers of tuesday's us session Via News Agency Tue, 26 Sep 2023 07:00:00 GMT
• car t-cell therapy for multiple myeloma market to observe ... PR Newswire Mon, 25 Sep 2023 07:00:00 GMT
• acute lymphocytic leukemia market to accelerate substantially by ... PR Newswire Wed, 13 Sep 2023 07:00:00 GMT
• adjuvant nivolumab versus ipilimumab in resected stage iii/iv ... Cancer Discovery Fri, 01 Sep 2023 08:22:16 GMT
• metastatic uveal melanoma market to grow rapidly by 2032, assesses delveinsight | key players - ideaya biosciences, verastem,pfize... PR Newswire Thu, 31 Aug 2023 07:00:00 GMT
• bempegaldesleukin plus nivolumab in untreated advanced ... ASCO Journals Thu, 31 Aug 2023 07:00:00 GMT
• global thalassemia market shows strong growth prospects ... GlobeNewswire Tue, 29 Aug 2023 07:00:00 GMT
• allogeneic hematopoietic cell transplantation improves outcome in ... ASCO Journals Tue, 22 Aug 2023 07:00:00 GMT
• hurler syndrome treatment market is expected to witness ... PharmiWeb.com Thu, 17 Aug 2023 07:00:00 GMT
Bellicum Pharmaceuticals, Inc(NASDAQ:BLCM) 
Bellicum Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel cellular immunotherapies for the treatment of hematological cancers and solid tumors in the United States and internationally. The company's clinical product candidates include BPX...
Website: http://www.bellicum.com
Founded: 2004
Full Time Employees: 107
Sector: Healthcare
Industry: Biotechnology